Literature DB >> 20133776

Synthetic design of strong promoters.

Michael R Schlabach1, Jimmy K Hu, Mamie Li, Stephen J Elledge.   

Abstract

We have taken a synthetic biology approach to the generation and screening of transcription factor binding sites for activity in human cells. All possible 10-mer DNA sequences were printed on microarrays as 100-mers containing 10 repeats of the same sequence in tandem, yielding an oligonucleotide library of 52,429 unique sequences. This library of potential enhancers was introduced into a retroviral vector and screened in multiple cell lines for the ability to activate GFP transcription from a minimal CMV promoter. With this method, we isolated 100 bp synthetic enhancer elements that were as potent at activating transcription as the WT CMV immediate early enhancer. The activity of the recovered elements was strongly dependent on the cell line in which they were recovered. None of the elements were capable of achieving the same levels of transcriptional enhancement across all tested cell lines as the CMV enhancer. A second screen, for enhancers capable of synergizing with the elements from the original screen, yielded compound enhancers that were capable of twofold greater enhancement activity than the CMV enhancer, with higher levels of activity than the original synthetic enhancer across multiple cell lines. These findings suggest that the 10-mer synthetic enhancer space is sufficiently rich to allow the creation of synthetic promoters of all strengths in most, if not all, cell types.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133776      PMCID: PMC2823900          DOI: 10.1073/pnas.0914803107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors.

Authors:  James T Kadonaga
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

4.  The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer.

Authors:  J S Fink; M Verhave; S Kasper; T Tsukada; G Mandel; R H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  In vivo sequence requirements of the SV40 early promotor region.

Authors:  C Benoist; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

6.  Powerful and versatile enhancer-promoter unit for mammalian expression vectors.

Authors:  M K Foecking; H Hofstetter
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

8.  Lentiviral vectors for enhanced gene expression in human hematopoietic cells.

Authors:  A Ramezani; T S Hawley; R G Hawley
Journal:  Mol Ther       Date:  2000-11       Impact factor: 11.454

9.  Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.

Authors:  Sangmi Chung; Therese Andersson; Kai-C Sonntag; Lars Björklund; Ole Isacson; Kwang-Soo Kim
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

10.  Variegation and silencing in a lentiviral-based murine transgenic model.

Authors:  Delphine Baup; Laurent Fraga; Eileen Pernot; Annette Van Acker; Anne-Sophie Vanherck; Karine Breckpot; Kris Thielemans; Stéphane Schurmans; Muriel Moser; Oberdan Leo
Journal:  Transgenic Res       Date:  2009-08-23       Impact factor: 2.788

View more
  41 in total

1.  Enzyme/Prodrug Systems for Cancer Gene Therapy.

Authors:  Obeid M Malekshah; Xuguang Chen; Alireza Nomani; Siddik Sarkar; Arash Hatefi
Journal:  Curr Pharmacol Rep       Date:  2016-10-19

Review 2.  Designer promoter: an artwork of cis engineering.

Authors:  Rajesh Mehrotra; Gauri Gupta; Riccha Sethi; Purva Bhalothia; Narayan Kumar; Sandhya Mehrotra
Journal:  Plant Mol Biol       Date:  2011-02-14       Impact factor: 4.076

3.  Development of a therapeutically important radiation induced promoter.

Authors:  Ryohei Ogawa; Akihiro Morii; Akihiko Watanabe; Zheng-Guo Cui; Go Kagiya; Shigekazu Fukuda; Kyo Kume; Takashi Hasegawa; Masanori Hatashita; Hironori Izumi; Tetsuya Ishimoto; Loreto B Feril
Journal:  Bioengineered       Date:  2012-08-28       Impact factor: 3.269

4.  Genetic engineering of somatic cells to study and improve cardiac function.

Authors:  Robert D Kirkton; Nenad Bursac
Journal:  Europace       Date:  2012-11       Impact factor: 5.214

5.  RNA-ID, a highly sensitive and robust method to identify cis-regulatory sequences using superfolder GFP and a fluorescence-based assay.

Authors:  Kimberly M Dean; Elizabeth J Grayhack
Journal:  RNA       Date:  2012-10-24       Impact factor: 4.942

Review 6.  Strategies for targeting primate neural circuits with viral vectors.

Authors:  Yasmine El-Shamayleh; Amy M Ni; Gregory D Horwitz
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

Review 7.  The grammar of transcriptional regulation.

Authors:  Shira Weingarten-Gabbay; Eran Segal
Journal:  Hum Genet       Date:  2014-01-05       Impact factor: 4.132

Review 8.  Synthetic biology in mammalian cells: next generation research tools and therapeutics.

Authors:  Florian Lienert; Jason J Lohmueller; Abhishek Garg; Pamela A Silver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01-17       Impact factor: 94.444

9.  Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.

Authors:  Ziying Yan; Xingshen Sun; Zehua Feng; Guiying Li; John T Fisher; Zoe A Stewart; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2015-04-20       Impact factor: 5.695

Review 10.  Nonhuman Primate Optogenetics: Recent Advances and Future Directions.

Authors:  Adriana Galvan; William R Stauffer; Leah Acker; Yasmine El-Shamayleh; Ken-Ichi Inoue; Shay Ohayon; Michael C Schmid
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.